钆塞酸二钠MR增强成像与CT增强成像诊断肝脏局灶性病变的对照研究  

A Comparative Study on the Diagnosis of Hepatic Focal Lesions by Gd-EOB-DTPA Enhanced MR Imaging and CT Contrastenhanced Imaging

作　　者：顾军[1] 张丹凤[1] 王同兴[1] GU Jun;ZHANG Dan-feng;WANG Tong-xing(Department of Radiology,Nanjing First Hospital,Nanjing Medical University,Nanjing 210006,Jiangsu Province,China)

机构地区：[1]南京医科大学附属南京医院(南京市第一医院)医学影像科,江苏南京210006

出　　处：《中国CT和MRI杂志》2023年第12期92-94,共3页Chinese Journal of CT and MRI

摘　　要：目的对比钆塞酸二钠MR增强成像与CT增强成像在诊断肝脏局限性病变中的诊断价值。方法纳入我院2015至2021年术前进行钆塞酸二钠MR增强成像和CT增强成像且具有术后病理诊断结果的患者66例。以术后病理结果为标准,对比钆塞酸二钠MR增强成像与CT增强成像对肝脏局灶性病变的诊断价值及准确性。结果66例患者中,有29例肝细胞肝癌、15例胆管细胞癌、12肝脏血管瘤、3例肝腺瘤、4例肝脏局灶性增生、3例肝脓肿。CT增强成像诊断的准确性分别为83%、80%、75%、67%、50%、67%,钆塞酸二钠MR增强成像诊断诊断的准确性分别为97%、100%、92%、67%、100%、100%。钆塞酸二钠MR增强成像的对肝脏局灶性病变诊断的准确率高于CT增强成像,差异具有统计学意义(P=0.005)。结论钆塞酸二钠MR增强成像对肝脏局灶性病变具有更高的诊断价值,优于CT增强成像。Objective To compare the value of the Gd-EOB-DTPA enhanced MR imaging and CT enhanced imaging in the diagnosis of liver localized lesions.Methods 70 patients with post-operative pathological diagnosis who underwent pre-operative Gd-EOB-DTPA enhanced MR imaging and CT enhanced imaging in our hospital from 2015 to 2021 were included.Based on post-operative pathological results,the diagnostic value and accuracy of the Gd-EOB-DTPA enhanced MR imaging and CT enhanced imaging for focal liver lesions were compared.Results Among the 66 patients,29 were hepatocellular carcinoma,15 were cholangiocarcinoma,12 were hepatic hemangioma,4 were focal hyperplasia,3 were hepatic adenoma,3 were liver abscess.The diagnostic accuracy of the CT enhanced imaging was 83%,80%,75%,67%,50%,67%,respectively.And the diagnostic accuracy of the Gd-EOB-DTPA enhanced MR imaging was 97%,100%,92%,67%,100%,100%,respectively.The accuracy of the MR imaging was higher than that of the CT enhanced imaging,the difference has statistical significance(P=0.005).Conclusion the Gd-EOB-DTPA enhanced MR imaging has a higher diagnostic value for hepatic focal lesions than that of the CT enhanced imaging.

关 键 词：钆塞酸二钠MR增强成像 CT增强成像 肝脏局灶性病变 诊断价值 

分 类 号：R445.2[医药卫生—影像医学与核医学]